Previously, metformin was found to downregulate the levels of obesity-related factors, including cholesterol and LDL, but to promote FGF21 expression in obese mice.23 Since FGF21 has been shown to be a key regulator of obesity,14 enhancing FGF21 expression has great potential therapeutic efficacy. Here, FGF21 is linked to obesity disorder.